Antigenics Inc.

Antigenics Inc.
Search
Products and TechnologiesClinical TrialsNewsroomInvestorsJobsAbout Antigenics
Glossary

Kidney cancer

E-mail this page

What is kidney cancer?

Kidney cancer is an abnormal, uncontrolled growth of cells in the kidney. According to the American Cancer Society, the most common type is renal cell cancer (also called renal cell carcinoma), which accounts for 85 percent of all kidney tumors.

Renal cell cancer may develop in one or both kidneys. In the early stages, kidney cancer usually causes no obvious signs or symptoms. As kidney cancer grows, it may invade organs near the kidney such as the liver, colon or pancreas. Kidney cancer cells may also break away from the original tumor and spread (or metastasize) to other parts of the body such as the lymph nodes, bones or lungs, with about one third of cases showing metastasis at the time of diagnosis.

  Kidneys

How many people get kidney cancer?

The American Cancer Society predicts that there will be about 51,190 new cases of kidney cancer in the United States this year, with almost 12,890 people dying from the disease.

What causes kidney cancer?

The exact cause of renal cell cancer is not known. However, certain risk factors are known to be associated with it, including smoking, overuse of certain painkillers, long-term dialysis, exposure to asbestos or cadmium, being overweight and eating a diet high in fat. In addition, some genetic factors and diseases such as tuberous sclerosis may increase one’s risk. Renal cell carcinoma typically occurs in people over the age of 50 and is twice as likely to occur in men than in women.

How is kidney cancer diagnosed?

In most cases, renal cell cancer is found only after a person has some sort of symptom of a problem. Because there are no blood or urine tests to specifically screen for renal cell cancer, it is sometimes found by accident when a person is having tests for something else.

Blood in the urine is the most common sign of kidney cancer, although this may also be caused by a bladder infection or some other less serious condition. Signs and symptoms of renal cell carcinoma can include:

  • Blood in the urine
  • Low back pain that is not caused by an injury
  • Mass or lump in the abdomen
  • Tiredness/fatigue
  • Rapid, unexplained weight loss
  • Fever that is unrelated to a cold, the flu or other infection
  • Swelling of ankles and legs
  • High blood pressure

These symptoms can also be caused by noncancerous conditions, but only your doctor can tell for sure. If there is any reason to suspect kidney cancer, the doctor will take your medical history, conduct a physical exam and may perform imaging tests such as CT scan, MRI or ultrasound to produce a detailed picture of the inside of the body. Laboratory tests such as urine and blood tests may also be performed to check for problems that may occur along with kidney cancer such as too few or too many red blood cells.

How is kidney cancer staged?

Staging is the process of finding out how far the cancer has spread. It is very important because, to a large extent, treatment and outlook for recovery depend on the stage of the cancer. In general, the lower the number, the less the cancer has spread.

Stage I The cancer has not spread and is only in the kidney.
Stage II The cancer has spread to the fatty tissue around the kidney, but not to the capsule around the kidney.
Stage III The cancer has spread to blood vessels or lymph nodes around the kidney.
Stage IV The cancer has spread to nearby organs (like the bowel or pancreas) or to other places (like the lungs).

Source: American Joint Committee on Cancer

Is kidney cancer fatal?

Prognosis for kidney cancer depends on how far the cancer has spread. For early-stage cancer, the five-year survival rate is 60 percent to 70 percent. If the cancer has spread to the lymph nodes, the five-year survival rate is 5 percent to 15 percent. If it has spread to other organs, the five-year survival rate is less than 5 percent.

How is kidney cancer treated?

Nephrectomy, or surgery to remove all or part of the kidney, is the main treatment for renal cell carcinoma, although a combination of treatments can be used. Tumor growth may be controlled by arterial embolization, a procedure that blocks the artery leading to the kidney to eliminate blood supply to the tumor. Radiation therapy may be used to reduce metastasis, although often renal cell carcinoma does not respond well to this type of treatment. In addition, hormonal therapy, chemotherapy and immunotherapy may be used to treat this disease.

Below are additional resources that may be helpful to you.

Kidney Cancer Association
Membership organization of patients, family members, physicians and researchers
National Cancer Institute
Government agency providing information and referrals
American Cancer Society
Programs of research, education, patient service, advocacy, and rehabilitation
Memorial Sloan-Kettering Cancer Center
World-renowned cancer center dedicated to the prevention, treatment and cure of cancer through patient care, research and education
MEDLINEplus Health Information
Service of the National Library of Information that provides information on conditions, diseases and wellness, a medical encyclopedia and access to consumer health libraries
CancerCare
Free counseling, education, information and referral and direct financial assistance
OncoLink
University of Pennsylvania’s cancer resource providing accurate cancer-related information
CancerGuide
Information resource focusing on technical information written by a former cancer patient
Cancervive
Services for cancer patients, survivors and family members dealing with the aftermath of the disease
Antigenics home pageSitemap for antigenics.comGlossaryContact Antigenics